InsiderTrades

Form 4 for AMRN AMARIN CORP PLC\UK

Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-30 · accession 0000950170-25-011824 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-01-31 2025-01-30+ AMRN Ketchum Steven B CSO M - OptEx — +169.7K 768.1K +28% —
DM 2025-01-31 2025-01-30+ AMRN Ketchum Steven B CSO F - Tax $0.62 -93.5K 747.0K -11% -$58.0K
DM 2025-01-31 2025-01-30+ AMRN Ketchum Steven B CSO M - OptEx $0.00 +66.7K 44.9K New $0
D 2025-01-31 2025-01-30 AMRN Ketchum Steven B CSO A - Grant $0.00 +51.5K 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-01-30 M A 51,500 — 722,340 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) Not applicable
2 Common Ordinary Shares 2025-01-30 F D 28,382 $0.62 693,958 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F5) Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.
3 Common Ordinary Shares 2025-01-31 M A 34,566 — 728,524 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) Not applicable
4 Common Ordinary Shares 2025-01-31 F D 19,197 $0.62 709,327 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F5) Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.
5 Common Ordinary Shares 2025-01-31 M A 44,933 — 754,260 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) Not applicable
6 Common Ordinary Shares 2025-01-31 F D 24,833 $0.62 729,427 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F5) Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.
7 Common Ordinary Shares 2025-01-31 M A 38,667 — 768,094 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) Not applicable
8 Common Ordinary Shares 2025-01-31 F D 21,093 $0.62 747,001 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F5) Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.
9 Derivative Restricted Stock Unit 2025-01-31 M A 38,667 $0.00 77,333 D $0.00 · — to — 38,667 Ordinary Shares (F9) Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. (F8) On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. (F3) Not applicable
10 Derivative Restricted Stock Unit 2025-01-30 A A 51,500 $0.00 0 D $0.00 · — to — 51,500 Ordinary Shares (F9) Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. (F2) On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 30, 2025, the second of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. (F3) Not applicable
11 Derivative Restricted Stock Unit 2025-01-31 M A 34,566 $0.00 0 D $0.00 · — to — 34,566 Ordinary Shares (F9) Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. (F6) On February 4, 2022, the Reporting Person was granted 103,700 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024 and January 31, 2025. (F3) Not applicable
12 Derivative Restricted Stock Unit 2025-01-30 M D 51,500 $0.00 0 D $0.00 · — to — 51,500 Ordinary Shares (F9) Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. (F2) On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 30, 2025, the second of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. (F3) Not applicable
13 Derivative Restricted Stock Unit 2025-01-31 M A 44,933 $0.00 44,934 D $0.00 · — to — 44,933 Ordinary Shares (F9) Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. (F7) On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. (F3) Not applicable